Berger MS - Search Results

1

Diffuse hemispheric glioma, H3 G34-mutant: Genomic landscape of a new tumor entity and prospects for targeted therapy.

Lucas CG, Mueller S, Reddy A, Taylor JW, Oberheim Bush NA, Clarke JL, Chang SM, Gupta N, Berger MS, Perry A, Phillips JJ, Solomon DA. Lucas CG, et al. Among authors: berger ms. Neuro Oncol. 2021 Nov 2;23(11):1974-1976. doi: 10.1093/neuonc/noab184. Neuro Oncol. 2021. PMID: 34519829 Free PMC article. No abstract available.

2

Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure.

Spence AM, Berger MS, Livingston RB, Ali-Osman F, Griffin B. Spence AM, et al. Among authors: berger ms. J Neurooncol. 1992 Feb;12(2):187-91. doi: 10.1007/BF00172671. J Neurooncol. 1992. PMID: 1560266 Clinical Trial.

3

Analysis of proliferative grade in glial neoplasms using antibodies to the Ki-67 defined antigen and PCNA in formalin fixed, deparaffinized tissues.

Hoyt JW, Gown AM, Kim DK, Berger MS. Hoyt JW, et al. Among authors: berger ms. J Neurooncol. 1995;24(2):163-9. doi: 10.1007/BF01078486. J Neurooncol. 1995. PMID: 7562003

4

Phase II study of paclitaxel in patients with recurrent malignant glioma.

Prados MD, Schold SC, Spence AM, Berger MS, McAllister LD, Mehta MP, Gilbert MR, Fulton D, Kuhn J, Lamborn K, Rector DJ, Chang SM. Prados MD, et al. Among authors: berger ms. J Clin Oncol. 1996 Aug;14(8):2316-21. doi: 10.1200/JCO.1996.14.8.2316. J Clin Oncol. 1996. PMID: 8708723 Clinical Trial.

5

The impact of technical adjuncts in the surgical management of cerebral hemispheric low-grade gliomas of childhood.

Berger MS. Berger MS. J Neurooncol. 1996 May-Jun;28(2-3):129-55. doi: 10.1007/BF00250195. J Neurooncol. 1996. PMID: 8832458 Review.

6

Low grade gliomas: functional mapping resection strategies, extent of resection, and outcome.

Berger MS, Rostomily RC. Berger MS, et al. J Neurooncol. 1997 Aug;34(1):85-101. doi: 10.1023/a:1005715405413. J Neurooncol. 1997. PMID: 9210055 Review.

7

Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.

Chang SM, Kuhn JG, Rizzo J, Robins HI, Schold SC Jr, Spence AM, Berger MS, Mehta MP, Bozik ME, Pollack I, Gilbert M, Fulton D, Rankin C, Malec M, Prados MD. Chang SM, et al. Among authors: berger ms. J Clin Oncol. 1998 Jun;16(6):2188-94. doi: 10.1200/JCO.1998.16.6.2188. J Clin Oncol. 1998. PMID: 9626220 Clinical Trial.

8

Phase II study of phenylacetate in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.

Chang SM, Kuhn JG, Robins HI, Schold SC, Spence AM, Berger MS, Mehta MP, Bozik ME, Pollack I, Schiff D, Gilbert M, Rankin C, Prados MD. Chang SM, et al. Among authors: berger ms. J Clin Oncol. 1999 Mar;17(3):984-90. doi: 10.1200/JCO.1999.17.3.984. J Clin Oncol. 1999. PMID: 10071293 Clinical Trial.

9

Intraoperative cortical mapping as a guide to the surgical resection of gliomas.

Matz PG, Cobbs C, Berger MS. Matz PG, et al. Among authors: berger ms. J Neurooncol. 1999 May;42(3):233-45. doi: 10.1023/a:1006122122404. J Neurooncol. 1999. PMID: 10433107 Review. No abstract available.

10

A Phase II study of paclitaxel in patients with recurrent malignant glioma using different doses depending upon the concomitant use of anticonvulsants: a North American Brain Tumor Consortium report.

Chang SM, Kuhn JG, Robins HI, Schold SC Jr, Spence AM, Berger MS, Mehta M, Pollack IF, Rankin C, Prados MD. Chang SM, et al. Among authors: berger ms. Cancer. 2001 Jan 15;91(2):417-22. doi: 10.1002/1097-0142(20010115)91:2<417::aid-cncr1016>3.0.co;2-9. Cancer. 2001. PMID: 11180089 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

831 results

Search Page